Semnur Pharmaceuticals, Inc. Liabilities Assumed
Semnur Pharmaceuticals, Inc. (SMNR) reported Liabilities Assumed of $12.91 million for the 12-month period ending 2025-12-31, per its S-1 filed 2026-05-12.
Financial Statements › Cash Flow
us-gaap:LiabilitiesAssumed1 · last filed 2026-05-12
| Period end | Liabilities Assumed 12 month |
|---|---|
| 2025-12-31 | $12.91M S-1 · filed 2026-05-12 |
| 2024-12-31 | $0.00 S-1 · filed 2026-05-12 |